NCT03100006 2022-06-13
ORION-01
National Cancer Centre, Singapore
Phase 1/2 Terminated
Clinical Trials
4 trialsNCT03162562 2020-12-22
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
CanariaBio Inc.
Phase 1 Terminated
NCT00034138 2007-12-18
A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
Unither Pharmaceuticals
Phase 1/2 Terminated
NCT00050375 2007-12-18
Clinical Trial for Ovarian Cancer (OvaRex®)
Unither Pharmaceuticals
Phase 3 Terminated